Influenza vaccine containing purified neuraminidase antigen and

Details Influenza vaccine containing purified neuraminidase antigen and Influenza vaccine containing purified neuraminidase antigen and

1975-01-16

1977-06-14

Rosen, Sam

Drug, bio-affecting and body treating compositions

Lymphokine

A61K 3918

Patent

active

040297632

ABSTRACT:
An influenza vaccine is disclosed which comprises, as an active ingredient, neuraminidase antigen which has been isolated from an antigenically functional virus and has substantial cross-reactivity with the influenza virus against which the vaccine is to be effective. The neuraminidase antigen can be derived from a virus antigenically representative of the contemporary or prevalent influenza virus subtype of interest, e.g., H3N2, the Hong Kong variant of influenza.

REFERENCES:
schulman et al., J. Virol., vol. 2, pp. 778-786, Aug. 1968.
Chemical Abstracts (1), vol. 78, entry 93005d, 1973.
Chemical Abstracts (2), vol. 80, entry 81006h, 1974.
Dowdle, New England J. Med., vol. 286, pp. 1360-1361, June 1972.
Kilbourne, Hospital Practice, Oct. 1971, pp. 103-114.
Kilbourne et al., J. Virology, vol. 2, pp. 281-288, Apr. 1968.
The Lancet, Aug. 5, 1972, pp. 264 & 265.
Rott et al., J. Gen. Virol., Vol. 22, pages 35-41, 1974.
Schild, J. Hyg. Camb., vol. 67, pp. 353-365, June 1969.

Affiliated with

Also associated with

Rating

Influenza vaccine containing purified neuraminidase antigen and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Influenza vaccine containing purified neuraminidase antigen and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Influenza vaccine containing purified neuraminidase antigen and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-10704